These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7455581)

  • 21. Hemodynamic effects of a calcium channel promoter, BAY y 5959, are preserved after chronic administration in ischemic heart failure in conscious dogs.
    Yi GH; Burkhoff D; Zhang H; Zhu SM; Zwas D; Wang J
    J Pharmacol Exp Ther; 1998 Aug; 286(2):760-6. PubMed ID: 9694931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Administration of milrinone before ischemia, in the presence of beta-blockade, to treat metabolic impairment and myocardial stunning in pigs.
    Sidi A; Muehlschlegel JD; Kirby DS; Lobato EB
    Acta Anaesthesiol Scand; 2008 Mar; 52(3):397-405. PubMed ID: 18269389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Value of calcium channel blockers in the prevention of ventricular fibrillation of ischemic etiology: experimental arguments].
    Timour Q; Freysz M; Aupetit JF; Loufoua J; Frassati D; Faucon G
    Bull Acad Natl Med; 1996 Jan; 180(1):215-26; discussion 226-7. PubMed ID: 8696877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular effects of verapamil and quinidine at normal and elevated ambient pressure.
    Stuhr LE; Risberg J; Bergø GW; Tyssebotn I
    Aviat Space Environ Med; 2001 Apr; 72(4):373-9. PubMed ID: 11318018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The comparative electrophysiologic and hemodynamic effects of verapamil in puppies and adult dogs.
    Gibson R; Driscoll D; Gillette P; Hartley C; Entman ML
    Dev Pharmacol Ther; 1981; 2(2):104-16. PubMed ID: 7472105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cardiopulmonary effects of CPPV (continuous positive pressure ventilation) and IRV (inverse ratio ventilation) in experimental myocardial ischemia].
    Hachenberg T; Meyer J; Sielenkämper A; Kraft W; Vogt B; Breithardt G; Lawin P
    Anaesthesist; 1993 Apr; 42(4):210-20. PubMed ID: 8488992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of carbocromene on ventricular fibrillation during acute myocardial ischemia in anesthetized dogs.
    Fiedler VB; Schneider S; Nitz RE
    Pharmacology; 1982; 25(2):96-101. PubMed ID: 7134263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of the calcium antagonist verapamil on necrosis following temporary coronary artery occlusion in dogs.
    Reimer KA; Lowe JE; Jennings RB
    Circulation; 1977 Apr; 55(4):581-7. PubMed ID: 837500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardioprotective effects of carbocromen in awake and anesthetized dogs with amitriptyline poisoning.
    Fiedler VB; Göbel H; Nitz RE
    J Cardiovasc Pharmacol; 1985; 7(4):666-72. PubMed ID: 2410706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lidoflazine in the early stages of acute myocardial ischaemia.
    Coker SJ; Fagbemi O; Parratt JR
    Br J Pharmacol; 1982 Jun; 76(2):347-54. PubMed ID: 7093589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of verapamil on regional myocardial blood flow and ST segment. Role of the induced bradycardia.
    Berdeaux A; Coutte R; Giudicelli J; Boissier J
    Eur J Pharmacol; 1976 Oct; 39(2):287-94. PubMed ID: 976324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of verapamil on infarct size following experimental coronary occlusion.
    Smith HJ; Singh BN; Nisbet HD; Norris RM
    Cardiovasc Res; 1975 Jul; 9(4):569-78. PubMed ID: 1182734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A comparative evaluation of the anti-ischemic action of verapamil in different models of myocardial ischemia].
    Gurbanov KK; Kovalev GV; Paperno AA
    Farmakol Toksikol; 1991; 54(4):21-3. PubMed ID: 1786814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of flurbiprofen on myocardial cell damage in acute myocardial ischemia.
    Smith EF; Carrow BA; Lefer AM
    Res Commun Chem Pathol Pharmacol; 1980 Jun; 28(3):413-33. PubMed ID: 7403657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hemodynamic effects of verapamil in patients with coronary insufficiency].
    Lamounier EN; Martinez EE; Herrmann JL; Guimarães RF; Martinez TL; Portugal OP
    Arq Bras Cardiol; 1978 Feb; 31 Suppl 1():11-14. PubMed ID: 678161
    [No Abstract]   [Full Text] [Related]  

  • 36. [Reduction of acute myocardial ischemia with verapamil. Evaluation by epicardial mapping].
    Belardinelli L; Lucchese FA; Wagner EM; Sant'Anna JR; Rodrigues R
    Arq Bras Cardiol; 1975 Dec; 28(6):599-607. PubMed ID: 1218007
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hemodynamic and electrocardiographic effects of verapamil in ischemic cardiopathy].
    Aquaro G; Belli R; Ravera A; Rey L; Possavino G; Trucco G; Pavia M; Idone P
    Boll Soc Ital Cardiol; 1981; 26(12):2143-6. PubMed ID: 7185381
    [No Abstract]   [Full Text] [Related]  

  • 38. Protective effect of Mercurascan after coronary artery ligation in the dog.
    Málek I; Kolc J; Mrhová O; Urbanová D; Málek P
    Eur J Cardiol; 1980; 12(1):55-62. PubMed ID: 7439234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Influence of verapamil on the electrophysiologic and mechanical effects of ischemia and reperfusion].
    Tucci PJ; Bregagnollo EA; Garcia RM
    Arq Bras Cardiol; 1982 Sep; 39(3):141-7. PubMed ID: 7186356
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of cicletanine on overpacing-induced ST-segment elevation in conscious rabbits. A comparison with verapamil.
    Szilvássy Z; Koltai M; Szekeres L; Tarrade T; Braquet P
    Eur J Pharmacol; 1991 Jul; 199(3):383-6. PubMed ID: 1915586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.